Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Accumulated Expenses (2016 - 2025)

Qiagen (QGEN) has disclosed Accumulated Expenses for 17 consecutive years, with $439.5 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 8.01% to $439.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $439.5 million through Dec 2025, up 8.01% year-over-year, with the annual reading at $439.5 million for FY2025, 8.01% up from the prior year.
  • Accumulated Expenses hit $439.5 million in Q4 2025 for Qiagen, up from $406.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $568.6 million in Q4 2021 to a low of $406.9 million in Q4 2024.
  • Historically, Accumulated Expenses has averaged $461.7 million across 5 years, with a median of $439.5 million in 2025.
  • Biggest five-year swings in Accumulated Expenses: surged 38.19% in 2021 and later dropped 16.26% in 2023.
  • Year by year, Accumulated Expenses stood at $568.6 million in 2021, then dropped by 14.49% to $486.2 million in 2022, then decreased by 16.26% to $407.2 million in 2023, then decreased by 0.07% to $406.9 million in 2024, then rose by 8.01% to $439.5 million in 2025.
  • Business Quant data shows Accumulated Expenses for QGEN at $439.5 million in Q4 2025, $406.9 million in Q4 2024, and $407.2 million in Q4 2023.